79 related articles for article (PubMed ID: 1502231)
1. Irreversible effects of 4-DAMP mustard on muscarinic receptors in vivo.
Thomas EA; Ehlert FJ
Proc West Pharmacol Soc; 1992; 35():233-7. PubMed ID: 1502231
[No Abstract] [Full Text] [Related]
2. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
[TBL] [Abstract][Full Text] [Related]
3. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.
Kukkonen J; Akerman KE
Biochem Biophys Res Commun; 1992 Dec; 189(2):919-24. PubMed ID: 1472064
[TBL] [Abstract][Full Text] [Related]
4. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
Miranda HF; Silva WI; Wolstenholme WW; Cuevas N
Gen Pharmacol; 1988; 19(3):417-20. PubMed ID: 3417103
[TBL] [Abstract][Full Text] [Related]
5. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
Thomas EA; Baker SA; Ehlert FJ
Mol Pharmacol; 1993 Jul; 44(1):102-10. PubMed ID: 8393516
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of brain cortex muscarinic receptors by 4-diphenylacetoxy-1-(2-chloroethyl) piperidine mustard.
Waelbroeck M; Renzetti AR; Tastenoy M; Barlow RB; Christophe J
Biochem Pharmacol; 1992 Jul; 44(2):285-90. PubMed ID: 1642642
[TBL] [Abstract][Full Text] [Related]
7. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
Yoshida A; Seki M; Nasrin S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Ehlert FJ; Yamada S
Urology; 2011 Sep; 78(3):721.e7-721.e12. PubMed ID: 21777958
[TBL] [Abstract][Full Text] [Related]
8. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
9. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
10. The use of irreversible ligands to inactivate receptor subtypes: 4-DAMP mustard and muscarinic receptors in smooth muscle.
Ehlert FJ; Griffin MT
Life Sci; 1998; 62(17-18):1659-64. PubMed ID: 9585153
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical studies on muscarinic cholinergic receptors of the rat brain: specific labeling of this protein using the photoaffinity method].
Moreno-Yanes JA; Salazar J
Acta Cient Venez; 1984; 35(1):48-57. PubMed ID: 6516684
[No Abstract] [Full Text] [Related]
12. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
13. Subclasses of muscarinic receptors and pirenzepine. Further experimental evidence.
Hammer R
Scand J Gastroenterol Suppl; 1982; 72():59-67. PubMed ID: 6957998
[No Abstract] [Full Text] [Related]
14. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and muscarinic receptor binding profiles of antagonist benzotriazole derivatives.
Cappello B; Greco G; Novellino E; Perissutti E; Santagada V; Silipo C; Vittoria A; Di Carlo R; Meli R; Muccioli G
Farmaco; 1993 Jul; 48(7):907-18. PubMed ID: 8397675
[TBL] [Abstract][Full Text] [Related]
16. Cardioselective muscarinic antagonists.
Fed Proc; 1987 Jun; 46(8):2523-35. PubMed ID: 3036606
[No Abstract] [Full Text] [Related]
17. Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors.
Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Schjelderup L; Aasen A; Lambrecht G; Christophe J
Eur J Pharmacol; 1992 Sep; 227(1):33-42. PubMed ID: 1426023
[TBL] [Abstract][Full Text] [Related]
18. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents.
Rezvani AH; Overstreet DH; Janowsky DS
Alcohol Alcohol; 1990; 25(1):3-7. PubMed ID: 2334493
[TBL] [Abstract][Full Text] [Related]
19. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
